Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.

Andrew Jacobs
Author: Andrew Jacobs

Written by

Andrew Jacobs

in

Clinical Trials, Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, LSD (Lysergic Acid Diethylamide), Lykos Therapeutics, Mental Health and Disorders, Post-Traumatic Stress Disorder, Psilocybin Mushrooms, Psychedelic and Hallucinogenic Drugs, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Therapy and Rehabilitation, Veterans
←Stellantis Will Lay Off Up to 2,450 at Michigan Truck Plant
Los Juegos Olímpicos en 9 momentos sexis→

More posts

  • Only A Millennial With A Perfect Memory Can Name All 100 Iconic ’90s Movies From A Single Image

  • Miley Cyrus Marries Maxx Morando in Palm Springs Wedding

  • Which “Hunger Games” Character Are You?

  • John Carpenter Reveals Robert Rodriguez In Running To Helm ‘Escape from New York’ Reimagining

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube